The commitment, differentiation, and expansion of mainstream α/β T cells during ontogeny depend on the highly controlled interplay of signals relayed by cytokines through their receptors on progenitor cells. The role of cytokines in the development of natural killer (NK)1+ natural T cells is less clearly understood. In an approach to define the role of cytokines in the commitment, differentiation, and expansion of NK1+ T cells, their development was studied in common cytokine receptor γ chain (γc) and interleukin (IL)-7 receptor α (IL-7Rα)–deficient mice. These mutations block mainstream α/β T cell ontogeny at an early prethymocyte stage. Natural T cells do not develop in γc-deficient mice; they are absent in the thymus and peripheral lymphoid organs such as the liver and the spleen. In contrast, NK1+ T cells develop in IL-7Rα–deficient mice in the thymus, and they are present in the liver and in the spleen. However, the absolute number of NK1+ T cells in the thymus of IL-7Rα–deficient mice is reduced to ∼10%, compared to natural T cell number in the wild-type thymus. Additional data revealed that NK1+ T cell ontogeny is not impaired in IL-2– or IL-4–deficient mice, suggesting that neither IL-2, IL-4, nor IL-7 are required for their development. From these data, we conclude that commitment and/or differentiation to the NK1+ natural T cell lineage requires signal transduction through the γc, and once committed, their expansion requires signals relayed through the IL-7Rα.
Natural T (NT) cells are a distinct lineage of lymphocytes whose function is thought to be immunoregulatory in nature because they secrete a wide variety of cytokines, most notably IL-4, upon activation. They express both natural killer (NKR-P1) and T (α/β and γ/δ TCR) cell markers. In mice, they are present in the liver, bone marrow, spleen, lymph node, and postnatal thymus (for review see reference 1). The development of CD4+8− or CD4−8− NT cells depends on the expression of nonclassical antigen presenting molecules such as CD1d1 (2–4) and possibly H-2TL (5). They express highly conserved α/β TCR; a large majority of them express Vα14Jα281 (85%) paired with Vβ8.2 (up to 70%) (6, 7). A similar subset of T cells also exists among the human peripheral blood CD4−8− lymphocytes (8, 9). Hence, NT cells are predicted to serve an evolutionarily conserved function. Although this function of NT cells remains elusive, their selective absence in autoimmune prone mice, such as MRL-lpr/lpr, B6-lpr/lpr, C3H-gld/gld, and BWF1 (10, 11) as well as nonobese diabetic (NOD; 12), suggests a role in the control of the disease. Moreover, the ability to delay or prevent the onset of disease either by the adoptive transfer of NKR-P1+ splenocytes (10) that includes both natural killer and NT cells, or by the administration of recombinant IL-4 (13), underscore the importance of NT cells in the physiology of normal immune responses.
Here we report that: (a) commitment and/or differentiation to NT cell lineage requires signaling through the common cytokine receptor γ chain (γc) because γc0/0 mice do not develop NKR-P1+ T cells in the thymus or in the peripheral lymphoid organs, (b) the expansion of the committed NT cells requires signals relayed through the IL-7Rα chain because although IL-7Rα0/0 mice develop NKR-P1+ cells, they are dramatically reduced in numbers compared to the wild type, and (c), signal(s) transduced through γc is not mediated by IL-2, IL-4, or IL-7 because neither IL-20/0, IL-40/0, nor IL-7Rα0/0 mutations affect NT cell development.
Materials And Methods
B6.IL-20/0 and IL-7Rα0/0 mice were purchased from the Jackson Laboratory (Bar Harbor, ME); B6.IL-20/0 were provided by D. Serreze (The Jackson Laboratory). R. Morawetz (National Institute of Allergy and Infectious Diseases, Bethesda, MD) provided B6.IL40/0 (14) and D. Roopenian (The Jackson Laboratory) provided B6.β2m0/0 and B6.IL-40/0 mice. B6.γc0/Y and B6.IL-7Rα0/0 mice were bred and genotyped at the National Heart, Lung and Blood Institute (Bethesda, MD; 15) and Immunex (Seattle, WA; 16), respectively.
Mononuclear Cell Preparation.
Mononuclear cells (MNC) from thymus and spleen were prepared by standard techniques. Intrahepatic MNC were prepared from minced liver lobes pressed through a wire mesh. The cells were suspended in 50 ml of RPMI-1640 (GIBCO BRL, Gaithersburg, MD) supplemented with 5% FCS (Hyclone Labs., Logan, UT) and allowed to settle for ∼10 min on ice. Liver MNC were separated from the hepatocytes by density centifugation over lympholyte M (Cederlane Labs. Ltd., Hornby, Canada). Cells at the interface were collected and washed with RPMI supplemented with 5% FCS.
Thymocytes (1–2 × 107) of individual animals 6 wk or older were stained for three-color flow cytometric analyses, as described previously (5), with anti–heat stable antigen (HSA)-PE (M1/69), anti–CD8α-PE (53-6.7), anti–CD44-FITC (IM7), and anti–NKR-P1 (NK1.1)-biotin (PK136), anti–TCR-β-biotin (H57-597), or anti–Vβ8.1,8.2-biotin (MR5-2). Thymocytes were also stained with anti–Ly6C-FITC (AL-21). When staining with anti–IL-2Rβ-PE (TM-β1), anti–HSA-FITC, and anti–CD8α-FITC were used to electronically gate in the HSAlow CD8low population. The biotinylated antibody was stained with streptavidin-RED670 (GIBCO BRL). HSAlowCD8low thymocytes were electronically gated and either CD44+NKR-P1+, CD44+ TCR-α/β+, and CD44+Vβ8.1,8.2+, Ly6ChighNKR-P1+, IL-2Rβ+ NKR-P1+, or IL-2Rβ+TCR-α/β+ NT cells were analyzed by flow cytometry using a FACScan® (Becton Dickinson, Mountain View, CA). Intrahepatic NT cells were stained with anti– NKR-P1-PE and anti–TCR-β-biotin or with anti–TCR-α/β-PE and anti–NKR-P1-biotin. Splenocytes were stained with anti–B220-FITC (RA3-6B2), anti–TCR-α/β-PE and anti–NKR- P1-biotin after blocking with anti-Fcγ III/II receptor antibody (2.4G2) for at least 15 min. NKR-P1+TCR-α/β+ cells were analyzed directly (liver) or after electronic gating within B220null MNC (spleen). All antibodies used in these experiments were purchased from PharMingen (San Diego, CA). Thymic NT cell number was calculated from the percentages of the double-positive CD44+ and NKR-P1+, TCR-α/β+ or Vβ8.1,8.2+ thymocytes within the HSAlowCD8low subset as described previously (5).
NT Cell Ontogeny in the Thymus of γc, IL-7Rα–, IL-2– and IL-4–deficient Mice.
The loss of γc expression as found in X-linked severe combined immunodeficiency patients or in mice results in impaired development of mainstream α/β T cells (15, 17). To determine whether γc deficiency affects NT cell ontogeny, we examined their development in the thymus of γc0/Y mice backcrossed to C57BL/6 for 4–8 generations. γc0/Y mice, >6 wk old, do not develop HSAlowCD8low CD44highNKR-P1+ thymocytes, whereas they are detected in the γc+/Y wild-type littermates (Fig. 1). Thus, akin to mainstream T cells, signaling through γc is important for NT cell ontogeny.
γc serves as an essential component of the multimeric receptors for IL-2, IL-4, IL-7, IL-9, and IL-15 (18). To determine which of the cytokines that use γc receptor affect NT cell development, the thymi of >6-wk-old B6.IL-20/0, B6.IL-40/0 and B6.IL-7Rα0/0 mice were analyzed. Mainstream T lymphocyte development is impaired in B6.IL-7 Rα0/0 mice, but proceeds normally in B6.IL-20/0 (19) and B6.IL-40/0 (20) mice. All three mutant mice develop CD44highNKR-P1+ T cells (Fig. 2,A). The repertoire of α/β-TCR is skewed towards Vβ8.1,8.2 usage in >40% (the percentage of TCR-α/β+ thymocytes that are Vβ8.1, 8.2+) of these NT cells (Fig. 2,A). Further data revealed that the NT cells that develop in B6.IL-40/0 and B6.IL-7 Rα0/0 mice also express Ly6C (Fig. 2,B) and that all the three mutant mice express IL-2Rβ (Fig. 2 C) similar to the NK1+ T cells that develop in the wild-type C57BL/6 mice. These data suggest that neither IL-2, IL-4, IL-7, nor thymic stromal-derived lymphopoietin (TSLP; IL-7Rα is a receptor component of IL-7 and TSLP; 16) are required for NT cell ontogeny.
To determine the absolute number of NT cells in the wild-type and the various mutant mice, thymocytes from them were electronically gated in the HSAlowCD8low population. The actual number of HSAlowCD8low cells was calculated from the observed percentages of this population, and the initial yield of thymocytes harvested from individual animals. Corresponding to the small size of the thymus (16), the number of HSAlowCD8low cells was dramatically reduced to ∼5% of the wild type in IL-7Rα0/0 mice (Fig. 2,D). The absolute number of CD44+NKR-P1+ T cells within the HSAlowCD8low population is reduced to ∼40% of wild type in IL-7Rα0/0 mice (Fig. 2,E, top). However, IL-7Rα0/0 thymus contains only up to 10% of NT cells that express TCR-α/β and Vβ8.1,8.2 compared to those of the wild type (Fig. 2,E, middle and bottom). The remaining CD44+NKR-P1+ thymocytes in the IL-7Rα0/0 mice are probably natural killer cells that also express these markers, but not the TCR-α/β (22). The reduced number of NT cells in the IL-7R0/0 mice then corresponds to the small size of its thymus (16). In contrast, the absolute number of NT cells in IL-20/0 mice is increased by 1.5–2-fold compared to the number of NKR-P1+ T cells in wild-type animals (Fig. 2 E). These data suggest that signals delivered through the IL-7Rα are not only important in maintaining thymic cellularity, but are also essential for the expansion of NT cells.
NT Cells in the Peripheral Lymphoid Organs of γc, IL-7Rα, and IL-2–deficient Mice.
NT cells are also present in peripheral lymphoid organs such as the liver, spleen, bone marrow, and lymph nodes; they also form a subset of intraepithelial lymphocytes of the gut (23). It is at present not clear whether NT cells develop in situ in these organs or whether they home here after their genesis in the thymus (22, 24, 25). To determine whether γc, IL-7Rα, and IL-2 deficiency affect NT cell development and/or homing to the liver and spleen, the presence of NKR-P1+TCR-α/β+ cells was analyzed in these mutant animals. We find that γc null mice contain dramatically reduced levels of NT cells in the liver and spleen (Fig. 3). IL-7Rα0/0 mice contained reduced numbers of NT cells in the liver (∼60% of wild type; Fig. 3,A) and in the spleen (∼25% of wild type; Fig. 3,B). In contrast, IL-2 null mutations had increased levels of NKR-P1+ T cells in the liver, but remained about the same in the spleen (Fig. 3). Thus, although γc is required for the development and/or homing of this subset of T cells to the liver and spleen, the signaling for this process does not require IL-2. Additionally, it is unclear whether IL-7Rα null mutation affects the development and/or homing of NT cells to the periphery, or whether it affects the expansion of this T cell subset in the liver and spleen as it does in the thymus.
The requirement for signal transduction through γc for NT cell development that does not involve IL-2 and IL-4 as well as, by extension, IL-7 and TSLP (evidenced by their development in IL-7Rα0/0 thymocytes) as the soluble mediator is noteworthy. Thus, the lack of NT cells in γc0/Y mice might be a reflection on the requirement for IL-9, IL-15, and/or an as yet unidentified cytokine as the signal transducer for their development. NKR-P1+ cells do not develop in mice with dysregulated expression of IL-2Rβ (26) or when the IL-2Rβ function is blocked with specific antibody (27). Whereas IL-9 uses only γc as part of its receptor complex (28, 29), IL-15 function depends on both the IL-2Rβ and γc (30). This suggests that IL-15 or a hithertofore undefined cytokine that uses both IL-2Rβ and γc specifies the soluble mediator function for NT cell ontogeny. If indeed an IL-2Rβ and γc-dependent cytokine(s) serves this function, how it selectively turns on NT cell development in fetal day 9 livers (25), and later in post-natal thymus (7), remains to be determined.
Human and mouse NK cells are predicted to develop from bipotential T/NK progenitor cells that commit to either T or NK cell lineage depending on the microenvironment of the developing precursor. Recent evidence suggests that the commitment to the NK lineage is strongly influenced by IL-15 (31–33). If NT and NK cells have a common precursor, then our data are consistent with the hypothesis that commitment to NKR-P1+ T cell lineage might be influenced by signals mediated by IL-15.
Two possible mechanisms can explain the lack of NT cell development in γc0/Y mice. Signaling through the γc may be critical for the commitment of the precursor cell to the NT cell lineage. An alternative mechanism would be that further differentiation of the already committed NT cells cannot proceed in the absence of signals from the γc. Current evidence supports the latter mechanism. It was recently demonstrated that γc null mice develop Vα14 and Vβ8 positive, the conserved TCR expressed by NT cells (6, 7), thymocytes within their CD4−8− subset (34). However, these thymocytes poorly respond to in vitro cross-linking of their TCR by secreting IL-4 (34), a characteristic of mature NT cells (35). This would suggest that commitment to NT cells has occurred in the thymus of γc null mice, but the committed precursor has not completely differentiated into this lineage.
Although IL-7Rα0/0 mice develop NT cells, their absolute numbers in the thymus are dramatically lower (∼10%) than those found in the wild-type mice. In vitro stimulation of unfractionated thymocytes with IL-7 results in the selective expansion of CD4+8− and CD4−8− thymocytes that express the Vβ8.2 TCR (36). In keeping with this and consistent with our results is the finding that IL-7 cytokine-deficient mice develop NT cells, but in reduced numbers (37). In this respect, it is also noteworthy that type I diabetes-prone NOD mice do not secrete IL-4 in response to in vivo cross-linking of TCR (12) suggesting that they do not develop NT cells. Type I diabetes is a Th1 disease that can be delayed or prevented by the administration of IL-4 to prediabetic NOD mice (13). The lack of IL-4 response of NOD mice to in vivo TCR cross-linking is reversible by IL-7 stimulation in vitro (12). Thus, in conclusion, akin to mainstream T cells, the commitment and/or differentiation to the NT cell lineage depends on signal transduction through the γc, and once committed, their expansion requires signals relayed through the IL-7Rα.
We thank M. Hunsinger and N. Schaffer for technical help; D. Roopenian for generous supply of B6.β2-m0/0 and B6.IL-40/0 mice; D. Serreze for generous supply of IL-20/0 and IL-2+/0 mice and R. Morawetz for B6.IL-40/0 mice for the initial experiments.
S. Joyce is the recipient of the American Cancer Society's Junior Faculty Research Award. This work is supported in part by grants to S. Joyce from the American Cancer Society (Institutional), the Juvenile Diabetes Foundation International and the National Institutes of Health (RO1 HL54977).
Address correspondence to Sebastian Joyce, Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, PA 17033. Phone: 717-531-4163; FAX: 717-531-6522; E-mail: email@example.com